Development of immunosorbents for apoB-containing lipoproteins apheresis.


Three types of sorbents were developed for the specific removal of atherogenic apoB-containing low-density lipoprotein (LDL) and lipoprotein LDL (a) (Lp[a]) from human plasma. Two sorbents contained monospecific sheep polyclonal or mouse monoclonal antibodies against human apoprotein B-100. The third one was intended for specific removal of Lp(a) and… (More)


Cite this paper

@article{Pokrovsky1995DevelopmentOI, title={Development of immunosorbents for apoB-containing lipoproteins apheresis.}, author={Sergei N Pokrovsky and Andrei V Sussekov and Irina Yu Adamova and Olga I Afanasieva and G. F. Benevolenskaya and Gennadiy A Konovalov and Valery V. Kukharchuk}, journal={Artificial organs}, year={1995}, volume={19 6}, pages={500-5} }